Poly(ethylene glycol) modification of β-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs Tian-Lu ChengBing-Mae ChenS. R. Roffler ORIGINAL ARTICLE Pages: 305 - 315
Interleukin-1α synergistic in vivo enhancement of cyclophosphamide- and carboplatin-mediated antitumor activity Wei-Dong YuMing-Jei ChangC. S. Johnson ORIGINAL ARTICLE Pages: 316 - 322
Comparison of the biological properties of two anti-mucin-1 antibodies prepared for imaging and therapy G. A. PieterszL. WenjunIan F. C. McKenzie ORIGINAL ARTICLE Pages: 323 - 328
Quantitative analysis of cytokine mRNA expression in peripheral blood mononuclear cells following treatment with interleukin-2 Masashi AdachiHiroshi InoueT. Akiyoshi ORIGINAL ARTICLE Pages: 329 - 334
Variable expression of tumor necrosis factor α in human malignant melanoma localized by in situ hybridization for mRNA Cecilia BergenwaldGunilla WestermarkB. Sander ORIGINAL ARTICLE Pages: 335 - 340
Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge Ian F. HermansAngela DaishF. Ronchese ORIGINAL ARTICLE Pages: 341 - 347
A phase II study of interferon α and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma A. PigaPaolo GiordaniRiccardo Cellerino SHORT COMMUNICATION Pages: 348 - 351